The management of patients with early Parkinson's disease.
Rascol
Olivier
O
Department of Clinical Pharmacology and Pharmacovigilance, Clinical Investigations Centre, INSERM, Toulouse, France.
Brefel-Courbon
C
C
Payoux
P
P
Ferreira
J
J
D000978:Antiparkinson Agents / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D004334:Drug Administration Schedule; D004409:Dyskinesia, Drug-Induced / Q000503:physiopathology / Q000517:prevention & control; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000191:economics / Q000503:physiopathology; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D018696:Neuroprotective Agents